Company Details
|
|
Address
|
Lombard Medical House, 4 Trident Park, Didcot, OX14 7HJ
|
|
Telephone
|
01235 750 800
|
|
Fax
|
01235 750 879
|
Executives
|
|
Chairman
|
Simon Neathercoat (0.20% holding)
|
|
Chief Executive
|
Brian Howlett (0.10% holding)
|
|
Finance Director
|
Timothy Hall (0.10% holding)
|
|
Non-Exec Director
|
Richard Johnston (26.10% holding)
|
Main Shareholders
|
|
|
Camden Partners II ALP: 24.6% Boston Scientific International: 9.1% Amvescap: 8.7% Jennison Health Sciences Fund: 8%
|
Advisers
|
|
Nominated Adviser
|
Nomura
|
|
Nominated Broker
|
Nomura
|
|
Solicitors
|
Berwin Leighton Paisner
|
|
Auditors
|
PricewaterhouseCoopers
|
|
Registrar
|
Capita Registrars
|
|
Commentary
|
|
Specialist medical device company
|
Company Data |
| Code |
LMT |
| Sedol |
GB00B0Q5QP |
| Shares In Issue |
133.980 m |
| Indices
|
Aim |
| Entry on AIM |
13/12/2005 |
| Interim Results |
Jul |
| Final Results |
Mar |
| Year End |
Dec |
| Accounts Due |
Jun |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|